Human Prothrombin Complex Concentrate - Global Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Pharma & Healthcare > Human Prothrombin Complex Concentrate - Global Top Players Market Share and Ranking 2025

Human Prothrombin Complex Concentrate - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-13
Report Id: 2765163
Industry: Pharma & Healthcare
Report Page: 116
Chart: 113

PDF Download

Publication Date: 2025-11-13
Report Id: 2765163
Industry: Pharma & Healthcare
Report Page: 116
Chart: 113

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Human Prothrombin Complex Concentrate Definition
1.2 Global Human Prothrombin Complex Concentrate Market Size and Forecast
1.2.1 By Consumption Value, Global Human Prothrombin Complex Concentrate Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Human Prothrombin Complex Concentrate Market Size, 2020-2031
1.2.3 Global Human Prothrombin Complex Concentrate Average Selling Price (ASP), 2020-2031
1.3 China Human Prothrombin Complex Concentrate Market Size and Forecast
1.3.1 By Consumption Value, China Human Prothrombin Complex Concentrate Market Size, 2020-2031
1.3.2 By Sales Quantity, China Human Prothrombin Complex Concentrate Market Size, 2020-2031
1.3.3 China Human Prothrombin Complex Concentrate Average Selling Price (ASP), 2020-2031
1.4 Share of China Human Prothrombin Complex Concentrate Market with Respect to the Global Market
1.4.1 By Consumption Value, China Human Prothrombin Complex Concentrate Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Human Prothrombin Complex Concentrate Market Share in Global, 2020-2031
1.4.3 Human Prothrombin Complex Concentrate Market Size: China VS Global, 2020-2031
1.5 Human Prothrombin Complex Concentrate Market Dynamics
1.5.1 Human Prothrombin Complex Concentrate Market Drivers
1.5.2 Human Prothrombin Complex Concentrate Market Restraints
1.5.3 Human Prothrombin Complex Concentrate Industry Trends
1.5.4 Human Prothrombin Complex Concentrate Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Human Prothrombin Complex Concentrate, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Human Prothrombin Complex Concentrate, Global Market Share by Company, 2020-2025
2.3 Human Prothrombin Complex Concentrate Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Human Prothrombin Complex Concentrate Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Prothrombin Complex Concentrate Concentration Ratio
2.6 Global Human Prothrombin Complex Concentrate Mergers & Acquisitions, Expansion Plans
2.7 Global Human Prothrombin Complex Concentrate Manufacturers Product Type
2.8 Head Office and Human Prothrombin Complex Concentrate Production Site of Key Manufacturer
2.9 Human Prothrombin Complex Concentrate Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Human Prothrombin Complex Concentrate, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Human Prothrombin Complex Concentrate, China Market Share by Company, 2020-2025
3.3 China Human Prothrombin Complex Concentrate Human Prothrombin Complex Concentrate Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Human Prothrombin Complex Concentrate Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Human Prothrombin Complex Concentrate Capacity by Region
4.3 Global Human Prothrombin Complex Concentrate Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Human Prothrombin Complex Concentrate Production by Region, 2020-2031
4.5 Global Human Prothrombin Complex Concentrate Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Human Prothrombin Complex Concentrate Industry Chain
5.2 Human Prothrombin Complex Concentrate Upstream Analysis
5.2.1 Human Prothrombin Complex Concentrate Core Raw Materials
5.2.2 Main Manufacturers of Human Prothrombin Complex Concentrate Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Prothrombin Complex Concentrate Production Mode
5.6 Human Prothrombin Complex Concentrate Procurement Model
5.7 Human Prothrombin Complex Concentrate Industry Sales Model and Sales Channels
5.7.1 Human Prothrombin Complex Concentrate Sales Model
5.7.2 Human Prothrombin Complex Concentrate Typical Distributors

6 Sights by Type
6.1 Human Prothrombin Complex Concentrate Classification by Type
6.1.1 Beriplex
6.1.2 Profilnine
6.1.3 Octaplex
6.1.4 Prothromplex
6.1.5 Cofact
6.1.6 Other
6.2 by Type, Global Human Prothrombin Complex Concentrate Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
6.4 by Type, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
6.5 by Type, Global Human Prothrombin Complex Concentrate Average Selling Price (ASP), 2020-2031

7 Sights by Composition
7.1 Human Prothrombin Complex Concentrate Classification by Composition
7.1.1 3-Factor PCC
7.1.2 4-Factor PCC
7.1.3 Recombinant Coagulation Complex
7.1.4 Other
7.2 by Composition, Global Human Prothrombin Complex Concentrate Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Composition, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
7.4 by Composition, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
7.5 by Composition, Global Human Prothrombin Complex Concentrate Average Selling Price (ASP), 2020-2031

8 Sights by Manufacturing Process
8.1 Human Prothrombin Complex Concentrate Classification by Manufacturing Process
8.1.1 Plasma-Derived
8.1.2 Recombinant Bioengineered
8.2 by Manufacturing Process, Global Human Prothrombin Complex Concentrate Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Manufacturing Process, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
8.4 by Manufacturing Process, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
8.5 by Manufacturing Process, Global Human Prothrombin Complex Concentrate Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Human Prothrombin Complex Concentrate Segment by Application
9.1.1 Hemophilia B
9.1.2 Vitamin K Deficiency
9.1.3 Other
9.2 by Application, Global Human Prothrombin Complex Concentrate Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
9.4 by Application, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
9.5 by Application, Global Human Prothrombin Complex Concentrate Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Human Prothrombin Complex Concentrate Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
10.3 By Region, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Human Prothrombin Complex Concentrate Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Human Prothrombin Complex Concentrate Market Size Market Share
10.5 Europe
10.5.1 Europe Human Prothrombin Complex Concentrate Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Human Prothrombin Complex Concentrate Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Human Prothrombin Complex Concentrate Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Human Prothrombin Complex Concentrate Market Size Market Share
10.7 South America
10.7.1 South America Human Prothrombin Complex Concentrate Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Human Prothrombin Complex Concentrate Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Human Prothrombin Complex Concentrate Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Human Prothrombin Complex Concentrate Consumption Value, 2020-2031
11.3 By Country, Global Human Prothrombin Complex Concentrate Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.4.2 by Type, United States Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.5.2 by Type, Europe Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.6.2 by Type, China Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.7.2 by Type, Japan Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.8.2 by Type, South Korea Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.10.2 by Type, India Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Human Prothrombin Complex Concentrate Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Human Prothrombin Complex Concentrate Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 CSL Behring
12.1.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
12.1.2 CSL Behring Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.1.3 CSL Behring Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 CSL Behring Company Profile and Main Business
12.1.5 CSL Behring Recent Developments
12.2 Grifols
12.2.1 Grifols Company Information, Head Office, Market Area, and Industry Position
12.2.2 Grifols Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.2.3 Grifols Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Grifols Company Profile and Main Business
12.2.5 Grifols Recent Developments
12.3 Octapharma
12.3.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
12.3.2 Octapharma Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.3.3 Octapharma Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Octapharma Company Profile and Main Business
12.3.5 Octapharma Recent Developments
12.4 Prothya Biosolutions
12.4.1 Prothya Biosolutions Company Information, Head Office, Market Area, and Industry Position
12.4.2 Prothya Biosolutions Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.4.3 Prothya Biosolutions Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Prothya Biosolutions Company Profile and Main Business
12.4.5 Prothya Biosolutions Recent Developments
12.5 Takeda
12.5.1 Takeda Company Information, Head Office, Market Area, and Industry Position
12.5.2 Takeda Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.5.3 Takeda Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Takeda Company Profile and Main Business
12.5.5 Takeda Recent Developments
12.6 RAAS
12.6.1 RAAS Company Information, Head Office, Market Area, and Industry Position
12.6.2 RAAS Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.6.3 RAAS Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 RAAS Company Profile and Main Business
12.6.5 RAAS Recent Developments
12.7 Hualan Bio
12.7.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
12.7.2 Hualan Bio Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.7.3 Hualan Bio Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Hualan Bio Company Profile and Main Business
12.7.5 Hualan Bio Recent Developments
12.8 BOHUI
12.8.1 BOHUI Company Information, Head Office, Market Area, and Industry Position
12.8.2 BOHUI Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.8.3 BOHUI Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 BOHUI Company Profile and Main Business
12.8.5 BOHUI Recent Developments
12.9 NUOYI BIO
12.9.1 NUOYI BIO Company Information, Head Office, Market Area, and Industry Position
12.9.2 NUOYI BIO Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.9.3 NUOYI BIO Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 NUOYI BIO Company Profile and Main Business
12.9.5 NUOYI BIO Recent Developments
12.10 SINOPHARM
12.10.1 SINOPHARM Company Information, Head Office, Market Area, and Industry Position
12.10.2 SINOPHARM Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.10.3 SINOPHARM Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 SINOPHARM Company Profile and Main Business
12.10.5 SINOPHARM Recent Developments
12.11 Guangdong Weilun
12.11.1 Guangdong Weilun Company Information, Head Office, Market Area, and Industry Position
12.11.2 Guangdong Weilun Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.11.3 Guangdong Weilun Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Guangdong Weilun Company Profile and Main Business
12.11.5 Guangdong Weilun Recent Developments
12.12 Weiguang Bio
12.12.1 Weiguang Bio Company Information, Head Office, Market Area, and Industry Position
12.12.2 Weiguang Bio Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.12.3 Weiguang Bio Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Weiguang Bio Company Profile and Main Business
12.12.5 Weiguang Bio Recent Developments
12.13 Kangbo Bio
12.13.1 Kangbo Bio Company Information, Head Office, Market Area, and Industry Position
12.13.2 Kangbo Bio Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.13.3 Kangbo Bio Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Kangbo Bio Company Profile and Main Business
12.13.5 Kangbo Bio Recent Developments
12.14 Huarun Boya
12.14.1 Huarun Boya Company Information, Head Office, Market Area, and Industry Position
12.14.2 Huarun Boya Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.14.3 Huarun Boya Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.14.4 Huarun Boya Company Profile and Main Business
12.14.5 Huarun Boya Recent Developments
12.15 Taibang Biologic
12.15.1 Taibang Biologic Company Information, Head Office, Market Area, and Industry Position
12.15.2 Taibang Biologic Human Prothrombin Complex Concentrate Models, Specifications, and Application
12.15.3 Taibang Biologic Human Prothrombin Complex Concentrate Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.15.4 Taibang Biologic Company Profile and Main Business
12.15.5 Taibang Biologic Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Human Prothrombin Complex Concentrate should grow from US$ 1408 million in 2024 to US$ 2724 million by 2031, with a CAGR of 9.7% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Human Prothrombin Complex Concentrate

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).In 2024, global Human prothrombin complex concentrate production reached approximately 4.73 m units, with an average global market price of around US$ 280 perunit.The average gross profit margin of this product is 80%.

The global market for Human Prothrombin Complex Concentrate is primarily driven by the expansion of clinical applications for plasma-derived products, heightened awareness of severe bleeding management, and the growing need for anticoagulant reversal therapy. With an aging population and increased use of anticoagulants, demand for rapid and safe hemostatic solutions continues to rise. Increased investments in trauma care systems and perioperative bleeding management for cardiovascular and hepatic patients across various countries are expanding the market potential for PCC products. Meanwhile, advances in recombinant technology and viral inactivation processes have enhanced product safety and accessibility, further propelling global market growth.

The development of the PCC market remains constrained by the limited availability of plasma resources, the complexity of production processes, and stringent regulatory requirements. Imbalances in plasma collection systems lead to supply chain instability, while manufacturing involves multiple high-precision steps such as viral inactivation, purification, and lyophilization, requiring significant technological expertise and cost investment. Differences in regulatory approval pathways, ethical standards, and drug traceability systems across countries may further delay product commercialization. Additionally, the emergence of recombinant clotting factors and synthetic hemostatic substitutes poses potential competition in specific clinical applications, raising the bar for innovation and compliance among traditional PCC manufacturers.

Downstream demand for PCC primarily originates from hospital emergency departments, intensive care units, and surgical applications. With the increasing volume of cardiovascular interventions, hepatobiliary surgeries, and trauma procedures, clinical use of PCC continues to expand. Reversal of anticoagulant-induced bleeding, particularly from warfarin therapy, has become one of its main use cases. Moreover, PCC usage is growing steadily in emergency and perioperative coagulation management. In developing regions, accessibility to plasma-derived products is improving, leading to rising import and local production demand for PCC, alongside a diffusion trend from tertiary hospitals to regional medical institutions.

The primary upstream raw material for PCC production is high-quality human plasma, whose stable supply is essential for maintaining industry competitiveness. Plasma must undergo rigorous screening, separation, and viral inactivation processes, and instability at any stage can impact product yield and safety. Global plasma collection is concentrated among a few major suppliers, and regional regulatory variations may lead to uneven supply. In addition to plasma, the production process requires auxiliary materials such as chromatographic resins, filtration membranes, and lyoprotectants, whose purity and batch consistency are critical for quality assurance. As the industry moves toward higher purity and safety standards, manufacturers are increasingly strengthening raw material traceability and consistency management across the supply chain.

This report studies and analyses global Human Prothrombin Complex Concentrate status and future trends, helps the client to determine the Human Prothrombin Complex Concentrate market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Prothrombin Complex Concentrate, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Human Prothrombin Complex Concentrate market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Human Prothrombin Complex Concentrate sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Human Prothrombin Complex Concentrate sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Human Prothrombin Complex Concentrate key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Human Prothrombin Complex Concentrate key producing regions, capacity, production, and year over year growth
(6) Human Prothrombin Complex Concentrate industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
RAAS
Hualan Bio
BOHUI
NUOYI BIO
SINOPHARM
Guangdong Weilun
Weiguang Bio
Kangbo Bio
Huarun Boya
Taibang Biologic

Market segment by Type, covers
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other

Market segment by Composition, covers
3-Factor PCC
4-Factor PCC
Recombinant Coagulation Complex
Other

Market segment by Manufacturing Process, covers
Plasma-Derived
Recombinant Bioengineered

Market segment by Application, can be divided into
Hemophilia B
Vitamin K Deficiency
Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Human Prothrombin Complex Concentrate product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Prothrombin Complex Concentrate market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Human Prothrombin Complex Concentrate market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Human Prothrombin Complex Concentrate, percent & CAGR, 2020-2031
Chapter 5: Human Prothrombin Complex Concentrate industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.